All Share Bazar News

All Bangla Share / Stock / Share Market DSE, CSE News

Home » Article » DSE News Archive » BXPHARMA Q2 Financials

BXPHARMA Q2 Financials

(Q2 Un-audited): EPS was Tk. 1.66 for October-December, 2017 as against Tk. 1.47 for October-December, 2016; EPS was Tk. 3.25 for July-December, 2017 as against Tk. 2.74 for July-December, 2016. NOCFPS was Tk. 3.14 for July-December, 2017 as against Tk. 2.56 for July-December, 2016. NAV per share was Tk. 63.77 as on December 31, 2017 and Tk. 59.07 as on December 31, 2016.

 

Add Comment | 0   comment
page number 1

Published On - 2018-01-29 02:55:08